T. Rowe Price Associates’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $672K | Buy |
|
|||||
|
2025
Q2 | $362K | Buy |
|
|||||
|
2025
Q1 | $268K | Buy |
|
|||||
|
2024
Q4 | $461K | Sell |
|
|||||
|
2024
Q3 | $569K | Buy |
|
|||||
|
2024
Q2 | $556K | Buy |
|
|||||
|
2024
Q1 | $657K | Buy |
|
|||||
|
2023
Q4 | $628K | Buy |
|
|||||
|
2023
Q3 | $561K | Sell |
|
|||||
|
2023
Q2 | $5.72M | Buy |
|
|||||
|
2023
Q1 | $5.1M | Sell |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $626K | Buy |
|
|||||
|
2022
Q2 | $449K | Sell |
|
|||||
|
2022
Q1 | $613K | Buy |
|
|||||
|
2021
Q4 | $721K | Sell |
|
|||||
|
2021
Q3 | $648K | Sell |
|
|||||
|
2021
Q2 | $511K | Sell |
|
|||||
|
2021
Q1 | $596K | Sell |
|
|||||
|
2020
Q4 | $551K | Buy |
|
|||||
|
2020
Q3 | $195K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $4.17M | Sell |
|
|||||
|
2018
Q3 | $5.41M | Sell |
|
|||||
|
2018
Q2 | $7.88M | Sell |
|
|||||
|
2018
Q1 | $10.1M | Buy |
|